Mark W. Rixon

2.2k citations
25 papers · 1.1k · 1 hit paper · h-index 13

Impact in

Papers in

    • T-cell and B-cell Immunology 10
    • Immune Cell Function and Interaction 7
    • Immunodeficiency and Autoimmune Disorders 3
    • Glycosylation and Glycoproteins Research 3
    • RNA modifications and cancer 3

Mark W. Rixon

23 papers receiving 1.1k citations

Mark W. Rixon's Hit Papers

TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease 2001 · 509 citations
5090+8+16Years since publication100200300400500

Peers

Mark W. Rixon
Comparison fields: 5 of 74
  • Immunology 566
  • Radiology, Nuclear Medicine and Imaging 289
  • Immunology and Allergy 66
  • Hematology 117
  • Genetics 106
Replace Eva Emmell with:
Eva Emmell United States
Cathy Quilici Australia
Xiaoyan Qiu China
José A. Brieva Spain
Consuelo Anzilotti United Kingdom
Ghislaine Bernard France
G Corte Italy
Jun-Ping Wei United States
Christian Kneitz Germany
Sietse Q. Nagelkerke Netherlands
Mark W. Rixon relative to Eva Emmell United States Eva Emmell's profile →
Citations per field
00.5×1.5×2.4×
Eva Emmell · 1×
Citations per year

Countries citing papers authored by Mark W. Rixon

Since Specialization
Citations

This map shows the geographic impact of Mark W. Rixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Rixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Rixon more than expected).

Fields of papers citing papers by Mark W. Rixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Rixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Rixon. The network helps show where Mark W. Rixon may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark W. Rixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Rixon Line = papers co-authored together Mark W. Rixon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease
Hit paper breakdown →
2001509
2 2015121
3 1983101
4 198370
5 198558
6 198141
7 198834
8 201634
9 200925
10 200022
11 202220
12 198320
13 200813
14 201212
15 199311
16 199011
17 198810
18 20209
19 20237
20 19886

About Mark W. Rixon

Mark W. Rixon is a scholar working on Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Cell Function and Interaction (7 papers), Blood properties and coagulation (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Glycosylation and Glycoproteins Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Immunology (566 citations), Radiology, Nuclear Medicine and Imaging (289 citations), Immunology and Allergy (66 citations), Hematology (117 citations) and Genetics (106 citations). Mark W. Rixon has collaborated with scholars based in United States, Germany and South Africa. Frequent co-authors include Earl W. Davie, Dominic W. Chung, Stacey R. Dillon, Sherri Mudri, Jane A. Gross, Kim Waggie, Ole Schou, Margaret Moore, Harald S. Haugen and Kevin P. Foley. Their work appears in journals such as Biochemistry, The Journal of Immunology, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact